Combined active and passive immunization against nicotine: Minimizing monoclonal antibody requirements using a target antibody concentration strategy

International Immunopharmacology

Volumn 11, Issue 11, 2011, Pages 1809-1815

  Cornish, Katherine E ^a,c   Harris, Andrew C ^b,c   Lesage, Mark G ^b,c   Keyler, Dan E ^a,c   Burroughs, Danielle ^c   Earley, Cathy ^c   Pentel, Paul R ^a,b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Immunotherapy; Locomotor sensitization; Monoclonal antibody; Nicotine; Pharmacokinetics; Vaccine

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY NIC311; NICOTINE; NICOTINE TARTRATE; NICOTINE VACCINE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; IMMUNOTHERAPY; LOCOMOTION; LOCOMOTOR SENSITIZATION; MALE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RAT; SENSITIZATION; THERAPY EFFECT; TOBACCO DEPENDENCE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ANTIBODY FORMATION; BRAIN; FEASIBILITY STUDIES; IMMUNIZATION, PASSIVE; MALE; MOTOR ACTIVITY; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; SMOKING; SMOKING CESSATION; TISSUE DISTRIBUTION; VACCINATION; VACCINES;

EID: 80054979538     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.07.009     Document Type: Article

References (34)

1. M.G. LeSage, D.E. Keyler, and P.R. Pentel Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies AAPS J 8 2006 E65 E75 (Pubitemid 43349386)
2. A. Elkashef, J. Biswas, J.B. Acri, and F. Vocci Biotechnology and the treatment of addictive disorders - new opportunities BioDrugs 21 2007 259 267 (Pubitemid 47104981)
3. A.Y. Moreno, and K.D. Janda Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependence Pharmacol Biochem Behav 92 2009 199 205
4. F.M. Orson, B.M. Kinsey, R.A.K. Singh, Y. Wu, T. Gardner, and T.R. Kosten Substance abuse vaccines Addiction reviews 2008 2008 Blackwell Publishing Oxford 257 269
5. J. Cornuz, S. Zwahlen, W.F. Jungi, J. Osterwalder, K. Klingler, and G. van Melle A vaccine against nicotine for smoking cessation: a randomized controlled trial PLoS One 3 2008
6. B.A. Martell, F.M. Orson, J. Poling, E. Mitchell, R.D. Rossen, and T. Gardner Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients a randomized, double-blind, placebo-controlled efficacy trial Arch Gen Psychiatry 66 2009 1116 1123
7. D.K. Hatsukami, D.E. Jorenby, D. Gonzales, N.A. Rigotti, E.D. Glover, and C.A. Oncken Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic Clin Pharmacol Ther 89 2011 392 399
8. G. Pitas, E.M. Laurenzana, D.K. Williams, S.M. Owens, and W.B. Gentry Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted Drug Metab Dispos 34 2006 906 912 (Pubitemid 43763745)
9. B. Anton, A. Salazar, A. Flores, M. Matus, R. Marin, and J.A. Hernandez Vaccines against morphine/heroin and its use as effective medication for preventing relapse to opiate addictive behaviors Hum Vaccin 5 2009 214 229
10. E.M. Laurenzana, H.P. Hendrickson, D. Carpenter, E.C. Peterson, W.B. Gentry, and M. West Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats Vaccine 27 2009 7011 7020
11. P.R. Pentel, and D.E. Keyler Vaccines to treat drug addiction M.M. Levine, New generation vaccines 3rd ed. 2004 Dekker New York 1057 1066
12. D.E. Keyler, S.A. Roiko, E. Benlhabib, M.G. Lesage, J.V. St Peter, and S. Stewart Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships Drug Metab Dispos 33 2005 1056 1061 (Pubitemid 41002789)
13. J.S. Hardin, W.D. Wessinger, G.R. Wenger, J.W. Proksch, E.M. Laurenzana, and S.M. Owens A single dose of monoclonal anti-phencyclidine IgG offers long-term reductions in phencyclidine behavioral effects in rats J Pharmacol Exp Ther 302 2002 119 126 (Pubitemid 34680429)
14. 2 and Fab after intravenous administration in the rat J Pharm Pharmacol 49 1997 277 281 (Pubitemid 27197013)
15. D.R. Getts, M.T. Getts, D.P. McCarthy, E.M.L. Chastain, and S.D. Miller Have we overestimated the benefit of human(ized) antibodies? MAbs 2 2010 682 694
16. P.R. Pentel, D.H. Malin, S. Ennifar, Y. Hieda, D.E. Keyler, and J.R. Lake A nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats Pharmacol Biochem Behav 65 2000 191 198 (Pubitemid 30018012)
17. P.R. Pentel, M.B. Dufek, S.A. Roiko, M.G. LeSage, and D.E. Keyler Differential effects of passive immunization with nicotine-specific antibodies on the acute and chronic distribution of nicotine to brain in rats J Pharmacol Exp Ther 317 2006 660 666
18. D.E. Keyler, S.A. Roiko, E. Benlhabib, M.G. LeSage, J.V. St Peter, and S. Stewart Monoclonal nicotine-specific antibodies reduce nicotine distribution to brain in rats: dose- and affinity-response relationships Drug Metab Dispos 33 2005 1056 1061 (Pubitemid 41002789)
19. P. Jacob III, M. Wilson, and N.L. Benowitz Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids J Chromatogr 222 1981 61 70 (Pubitemid 11141159)
20. Y. Hieda, D.E. Keyler, J.T. VanDeVoort, R.S. Niedbala, D.E. Raphael, and C.A. Ross Immunization of rats reduces nicotine distribution to brain Psychopharmacology (Berl) 143 1999 150 157 (Pubitemid 29187639)
21. D.E. Keyler, D. Shoeman, M.G. Lesage, A.D. Calvin, and P.R. Pentel Maternal vaccination against nicotine reduces nicotine distribution to fetal brain in rats J Pharmacol Exp Ther 305 2003 587 592 (Pubitemid 36459174)
22. S.A. Roiko, A.C. Harris, D.E. Keyler, M.G. LeSage, Y. Zhang, and P.R. Pentel Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats J Pharmacol Exp Ther 325 2008 985 993 (Pubitemid 351724343)
23. J.R. Daniels, W.D. Wessinger, W.C. Hardwick, M. Li, M.G. Gunnell, and C.J. Hall Effects of anti-phencyclidine and anti-(+)-methamphetamine monoclonal antibodies alone and in combination on the discrimination of phencyclidine and (+)-methamphetamine by pigeons Psychopharmacology 185 2006 36 44 (Pubitemid 43289611)
24. W.B. Gentry, E.M. Laurenzana, D.K. Williams, J.R. West, R.J. Berg, and T. Terlea Safety and efficiency of an anti-(+)-methamphetamine monoclonal antibody in the protection against cardiovascular and central nervous system effects of (+)-methamphetamine in rats Int Immunopharmacol 6 2006 968 977
25. A.B. Norman, M.K. Norman, W.R. Buesing, M.R. Tabet, V.L. Tsibulsky, and W.J. Ball The effect of a chimeric human/murine anti-cocaine monoclonal antibody on cocaine self-administration in rats J Pharmacol Exp Ther 328 2009 873 881
26. M.R. Carrera, J.A. Ashley, T.Z. Hoffman, S. Isomura, P. Wirsching, and G.F. Koob Investigations using immunization to attenuate the psychoactive effects of nicotine Bioorg Med Chem 12 2004 563 570 (Pubitemid 38102225)
27. M.A. Tabrizi, and L.K. Roskos Preclinical and clinical safety of monoclonal antibodies Drug Discov Today 12 2007 540 547 (Pubitemid 47031663)
28. D. Dierickx, A. Delannoy, K. Saja, G. Verhoef, and D. Provan Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders Am J Hematol 86 2010 278 291
29. L.G. Presta Engineering of therapeutic antibodies to minimize immunogenicity and optimize function Adv Drug Deliv Rev 58 2006 640 656 (Pubitemid 44262411)
30. D.K. Hatsukami, S. Rennard, D. Jorenby, M. Fiore, J. Koopmeiners, and A. de Vos Safety and immunogenicity of a nicotine conjugate vaccine in current smokers Clin Pharmacol Ther 78 2005 456 467 (Pubitemid 41698900)
31. M.G. LeSage, D.E. Keyler, Y. Hieda, G. Collins, D. Burroughs, and C. Le Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats Psychopharmacology (Berl) 184 2006 409 416 (Pubitemid 43255857)
32. S.D. Satoskar, D.E. Keyler, M.G. LeSage, D.E. Raphael, C.A. Ross, and P.R. Pentel Tissue-dependent effects of immunization with a nicotine conjugate vaccine on the distribution of nicotine in rats Int Immunopharmacol 3 2003 957 970 (Pubitemid 36694866)
33. Y. Hieda, D.E. Keyler, S. Ennifar, A. Fattom, and P.R. Pentel Vaccination against nicotine during continued nicotine administration in rats: immunogenicity of the vaccine and effects on nicotine distribution to brain Int J Immunopharmacol 22 2000 809 819 (Pubitemid 30616407)
34. F. Vincenti, R. Kirkman, S. Light, G. Bumgardner, M. Pescovitz, and P. Halloran Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation N Engl J Med 338 1998 161 165 (Pubitemid 28041863)